Hypoxia‐related lncRNAs to build prognostic classifier and reveal the immune characteristics of EGFR wild type and low expression of PD‐L1 squamous and adenocarcinoma NSCLC
Abstract Background Recently, the development and application of targeted therapies like tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) have achieved remarkable survival benefits in non‐small cell lung cancer (NSCLC) treatment. However, epidermal growth factor receptor (EG...
Main Authors: | Fang Zhao, Min Wang, Jie Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.4126 |
Similar Items
-
The role of lncRNAs and exosomal lncRNAs in cancer metastasis
by: Yutong Zhang, et al.
Published: (2023-09-01) -
Microarray profiling of differentially expressed lncRNAs and mRNAs in lung adenocarcinomas and bioinformatics analysis
by: Fei He, et al.
Published: (2020-10-01) -
The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
by: Wenxiao Jiang, et al.
Published: (2021-09-01) -
An autophagy-associated lncRNAs model for predicting the survival in non-small cell lung cancer patients
by: Jing Hu, et al.
Published: (2022-09-01) -
Identification and Functional Analysis of lncRNAs Responsive to Hypoxia in <i>Eospalax fontanierii</i>
by: Zhiqiang Hao, et al.
Published: (2021-11-01)